Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
A Phase IIb Randomized Controlled Trial of the TLPLDC Vaccine as Adjuvant Therapy After Surgical Resection of Stage III/IV Melanoma: A Primary AnalysisAnn. Surg. Oncol 2021 Feb 27;[EPub Ahead of Print], TJ Vreeland, GT Clifton, DF Hale, RC Chick, AT Hickerson, JL Cindass, AM Adams, PMK Bohan, RHI Andtbacka, AC Berger, JW Jakub, JJ Sussman, AM Terando, T Wagner, GE Peoples, MB Faries
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.